Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS), explores how potential FDA, EMA, and global regulatory approval of MDMA-assisted therapy for PTSD may contribute to a post-prohibition future.

ALPS - Awareness Lectures of Psychedelic Science
We aim to bring together several outstanding researchers and clinicians working with psychedelic substances. Its purpose is to promote the latest scientific and clinical knowledge on the subject and discuss about key issues of the domain.

https://www.alps.foundation/
https://www.facebook.com/ALPS.Conference
https://www.instagram.com/alps.conference/
https://twitter.com/ALPSconference
https://www.linkedin.com/company/alps-awareness-lectures-on-psychedelic-science/?viewAsMember=true